Literature DB >> 25721307

A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.

Graham P Collins1, Toby A Eyre2, Kim M Linton3, John Radford3, Grant D Vallance2, Elizabeth Soilleux4, Chris Hatton2.   

Abstract

Entities:  

Keywords:  AZD1152; Aurora B kinase; barasertib; diffuse large B-cell lymphoma; lymphoid malignancies

Mesh：

Substances：

Year:  2015        PMID： 25721307     DOI： 10.1111/bjh.13333

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

Review 1.  The Relevance of Aurora Kinase Inhibition in Hematological Malignancies.

Authors:  Caio Bezerra Machado; Emerson Lucena DA Silva; Beatriz Maria Dias Nogueira; Jean Breno Silveira DA Silva; Manoel Odorico DE Moraes Filho; Raquel Carvalho Montenegro; Maria Elisabete Amaral DE Moraes; Caroline Aquino Moreira-Nunes
Journal:  Cancer Diagn Progn       Date:  2021-07-03

Review 2.  The Aurora kinase inhibitors in cancer research and therapy.

Authors:  Jonas Cicenas
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-01       Impact factor: 4.553

3.  Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis.

Authors:  Jue Jiang; Jingchao Wang; Ming Yue; Xiaolian Cai; Tianci Wang; Chao Wu; Hexiu Su; Yanwu Wang; Meng Han; Yingchi Zhang; Xiaofan Zhu; Peng Jiang; Peng Li; Yonghua Sun; Wuhan Xiao; Hui Feng; Guoliang Qing; Hudan Liu
Journal:  Cancer Cell       Date:  2020-02-10       Impact factor: 31.743

4.  Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.

Authors:  Hiroaki Goto; Yuki Yoshino; Mieko Ito; Junichi Nagai; Tadashi Kumamoto; Takesi Inukai; Yukari Sakurai; Naoyuki Miyagawa; Dai Keino; Tomoko Yokosuka; Fuminori Iwasaki; Satoshi Hamanoue; Masae Shiomi; Shoko Goto
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-06       Impact factor: 3.333

5.  Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosis.

Authors:  Mark D Gurden; Simon J Anderhub; Amir Faisal; Spiros Linardopoulos
Journal:  Oncotarget       Date:  2016-07-18

6.  Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity.

Authors:  Yuanfeng Zhou; Ming Li; Xinyou Yu; Ting Liu; Tian Li; Li Zhou; Wenbin Liu; Wei Li; Feng Gao
Journal:  Int J Biol Sci       Date:  2018-09-07       Impact factor: 6.580

Review 7.  Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.

Authors:  Naheed Arfin Borah; Mamatha M Reddy
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

8.  Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors.

Authors:  Yongkun Sun; Lin Yang; Xuezhi Hao; Yutao Liu; Jinwen Zhang; Zhiqiang Ning; Yuankai Shi
Journal:  J Hematol Oncol       Date:  2019-01-14       Impact factor: 17.388

9.  Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis.

Authors:  Rajesh K Kasam; Sudhir Ghandikota; Divyalakshmi Soundararajan; Geereddy B Reddy; Steven K Huang; Anil G Jegga; Satish K Madala
Journal:  EMBO Mol Med       Date:  2020-08-06       Impact factor: 12.137

Review 10.  Alternative approaches to target Myc for cancer treatment.

Authors:  Chen Wang; Jiawei Zhang; Jie Yin; Yichao Gan; Senlin Xu; Ying Gu; Wendong Huang
Journal:  Signal Transduct Target Ther       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.